1.       Aboulhosn J, Child JS. Echocardiographic evaluation of congenital left ventricular outflow obstruction. Echocardiography. 2015;32(Suppl 2):S140–S147.

2.       Adams EE, Davidson WR Jr, Swallow NA, Nickolaus MJ, Myers JL, Clark JB: Long-term results of the subclavian flap repair for coarctation of the aorta in infants. World J Pediatr Congenit Heart Surg. 2013, 4:13-18. 10.1177/2150135112466878.

3.       Atz AM, Hawkins JA, Lu M, et al. Surgical management of complete atrioventricular septal defect: Association with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011;141:1371–1379.

4.       Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucher- lapati R, Seidman JG, Seidman CE. Mutations in human TBX5 [cor- rected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15:30 –35.

5.       Bayer ML, Frommelt PC, Blei F, et al. Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the international PHACE syndrome registry). Am J Cardiol 2013;112:1948–52.

6.       Beerbaum P, Körperich H, Barth P, Esdorn H, Gieseke J, Meyer H. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation 2001; 103: 2476–82.

7.       Bol Raap G, Meijboom FJ, Kappetein AP, Galema TW, Yap S-C, Bogers AJJC. Long-term follow-up and quality of life after closure of ventricular septal defect in adults. Eur J Cardiothorac Surg 2007; 32: 215–19.

8.       Braunwald E, Goldblatt A, Aygen MM, Rockoff SD, Morrow AG. Congenital aortic stenosis. I. Clinical and hemodynamic findings in 100 patients. II. Surgical treatment and the results of operation. Circulation. 1963;27:426–462.  

9.        Canniffe C, Ou P, Walsh K, et al. Hypertension after repair of aortic coarctation–a systematic review. Int J Cardiol 2013;167:2456–61.

10.    Caputo S, Capozzi G, Russo MG, et al. Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect. Eur Heart J 2005; 26: 2179–84.

11.    Carlgren LE. The incidence of congenital heart disease in children born in Gothenburg 1941–1950. Br Heart J. 1959;21:40–50.

12.    Clark EB. Etiology of congenital cardiovascular malformations. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, ed. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001;1: 64 –79.

13.    Clyman R, Wickremasinghe A, Jhaveri N, et al; Ductus Arteriosus Feed or Fast with Indomethacin or Ibuprofen (DAFFII) Investigators. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. J Pediatr. 2013;163 (2):406–411.

14.     Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36(2):123–129.

15.    Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039–50.

16.    Duffels MGL, Engelfriet PM, Berger RMF, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 2007; 120: 198–24.

17.    Feltes TF, Bacha E, Beekman RH 3rd, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607–2652.   

18.    Fine N, Dias B, Shoemaker G, Mehta S. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review. Can J Cardiol 2009; 25: e63–68.

19.    Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998;80:213–217. 

20.    Früh S, Knirsch W, Dodge-Khatami A, et al. Comparison of surgical and interventional therapy of native and recurrent aortic coarctation regarding different age groups during childhood. Eur J Cardiothorac Surg 2011;39:898–904.

21.    Gabriel HM, Heger M, Innerhofer P, et al. Long-term outcome
of patients with ventricular septal defect considered not to require surgical closure durin childhood.JAmCollCardiol2002;39:1066–71.

22.    Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet. 2014 May 31;383(9932):1921-32.

23.    Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–900.

24.    Hoffman JI. Incidence of congenital heart disease: I—postnatal incidence. Pediatr Cardiol 1995;16:103–13.

25.    Houston AB, Lim MK, Doig WB, Reid JM, Coleman EN. Doppler assessment of the interventricular pressure drop in patients with ventricular septal defects. Br Heart J 1988; 60: 50–56.

26.    Karaosmanoglu AD, Khawaja RD, Onur MR, et al. CT and MRI of aortic coarctation: pre- and postsurgical findings. AJR Am J Roentgenol 2015;204:W224–33.

27.    Kilner PJ, Geva T, Maemmerer H, Trindade PT, Schwitter J, Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010; 31: 794–805.

28.    Kleinman CS, Tabibian M, Starc TJ, Hsu DT, Gersony WM. Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr 2007; 150: 583–86.

29.    Kleinman CS. Echocardiographic guidance of catheter-based treatments of atrial septal defect: transesophageal echocardiography remains the gold standard. Pediatr Cardiol 2005; 26: 128–34.

30.    Kumar RK, Sandoval J. Advanced pulmonary vascular disease: the Eisenmenger syndrome. Cardiol Young 2009; 19: 622–26.

31.    Masutani S, Senzaki H. Left ventricular function in adult patients with atrial septal defect: implication for development of heart failure after transcatheter closure. J Card Fail 2011; 17: 957–63.

32.    McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2.5 mutations in patients with congenital heart disease.J Am Coll Cardiol 2003; 42: 1650–55.

33.    Mehta PK, Simpson L, Lee EK, Lyle TA, McConnell ME, Book WM. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects. Tex Heart Inst J 2008; 35: 256–61.

34.    Miller A, Riehle-Colarusso T, Siffel C, Frías JL, Correa A. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A 2011; 155A:2137–45.

35.    Minette MS, Sahn DJ. Ventricular septal defects. Circulation 2006; 114: 2190–97.

36.    Nakagawa K, Akagi T, Taniguchi M, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012; 80: 84–90.

37.    Neill CA, Ferencz C, Sabiston DC, Sheldon H. The familial occurrence of hypoplastic right lung with systemic arterial supply and venous drainage “scimitar syndrome.” Bull Johns Hopkins Hosp. 1960;107:1–21.

38.    Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57–e185.

39.    Noonan JA. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child. 1968;116:373–380.

40.    Patel DK, Green KD, Fudim M, Harrell FE, Wang TJ, Robbins MA. Racial differences in the prevalence of severe aortic stenosis. J Am Heart Assoc. 2014;3(3):e000879

41.    Raghib G, Ruttenberg HD, Anderson RC, Amplatz K, Adams P Jr, Edwards JE. Termination of left superior vena cava in left atrium, atrial septal defect, and absence of coronary sinus; a developmental complex. Circulation 1965; 31: 906–18.

42.    Reefhuis J, Honein MA, Schieve LA, Correa A, Hobbs CA, Rasmussen SA, and the National Birth Defects Prevention Study. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 2009; 24: 360–66.

43.    Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995; 26: 1545–48.

44.    Roos-Hesselink JW, Scholzel BE, Heijdra RJ, et al. Aortic valve and aortic arch pathology after coarctation repair. Heart. 2003, 89:1074-1077. 10.1136/heart.89.9.1074.

45.    Russell GA, Berry PJ, Watterson K, et al. Patterns of ductal tissue in coarctation of the aorta in the first three months of life. J Thorac Cardiovasc Surg 1991;102:596–601.

46.    Samanek M. Prevalence at birth, “natural” risk and survival with atrioventricular septal defect. Cardiol Young. 1991;1:285–289. 

47.    Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2–5. Science. 1998;281: 108 –111.

48.    Scully BB, Morales DLS, Zafar F, McKenzie ED, Fraser CD, Heinle JS. Current expectations for surgical repair of isolated ventricular septal defects. Ann Thorac Surg 2010; 89: 544–49.

49.    Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease—long-term follow-up and prediction of outcome after surgical correction. Circulation 1987; 76: 1037–42.

50.    Tomita H, Fuse S, Hatakeyama K, Chiba S. Epinephrine-induced constriction of the persistent ductus arteriosus and its relation to distensibility. Jpn Circ J. 1998;62:913–914.

51.    Tweddell JS, Pelech AN, Frommelt PC. Ventricular septal defect and aortic valve regurgitation: pathophysiology and indications for surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006: 9: 147–52.

52.    Tynan M, Jones O, Joseph MC, Deverall PB, Yates AK. Relief of pulmonary valve stenosis in first week of life by percutaneous balloon valvuloplasty. Lancet. 1984;1:273.

53.    Ucar T, Fitoz S, Tutar E, Atalay S, Uysalel A. Diagnostic tools in the preoperative evaluation of children with anomalous pulmonary venous connections. Int J Cardiovasc Imaging. 2008;24(2):229–235.

54.    Valente AM, Sena L, Powell AJ, Del Nido PJ, Geva T. Cardiac magnetic resonance imaging evaluation of sinus venosus defects: comparison to surgical findings. Pediatr Cardiol 2007; 28: 51–56.

55.    Van de Bruaene A, Delcroix M, Pasquet A, et al. The Belgian Eisenmenger syndrome registry: implications for treatment strategies. Acta Cardiol 2009; 64: 447–53.

56.    Vergales JE, Gangemi JJ, Rhueban KS, et al. Coarctation of the aorta - the current state of surgical and transcatheter therapies. Curr Cardiol Rev 2013;9:211–9.

57.    Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 2004; 93: 1374–77.

58.    Wort SJ. Sildenafil in Eisenmenger syndrome: safety first. Int J Cardiol 2007; 120: 314–16.

59.    Yalonetsky S, Lorber A. Comparative changes of pulmonary artery pressure values and tricuspid valve regurgitation following transcatheter atrial septal defect closure in adults and the elderly. Congenit Heart Dis 2009; 4: 17–20.